Theratechnologies Inc (TH.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Theratechnologies Inc (TH.TO)

Wealthica The ultimate 360° Tracker Your financial life in one place, automatically

4.47

-0.23 (4.89%)

as of Sep 26, 2025, 7:45:03 pm Market Open.

20 watching

WAIT

Best quarter is the last one, which ends in February. December - May is optimal holding period. Lately, it's been trending lower. No reason to be enticed just yet. Want to see support at major moving averages.

COMMENT

Biotechs can be very volatile. 2016 to early-2018 saw an uptrend, then turned down to the present. Be cautious now. TH-T is waiting for FDA approvals of its drugs which could swing this up sharply.

BUY

If this was a fundamental disaster, it's going to be news driven. If it's the only company in the sector that's falling, tech analysis goes out the window. It's at a pocket after a big pullback. It's a gamble, but it's probably at a point to buy right now.

PARTIAL BUY

Every biotech company always has some life-altering technology, and it's always way too positive. Small-mid caps like this can have big moves. Reversing a sideways trend, and breaking up to new levels, so that's positive. Maybe some movement up to $12. Take a small position, don't expose yourself too much. Support will be around $8.50, and if it breaks, start exiting.

RISKY

Had a sharp run, then a sharp pullback. Technically it looks good here. You could buy it here. But he doesn't know this company well.

PAST TOP PICK

(A Top Pick July 10/17 - Down 13%.) He knew it was high risk. The biggest risk would be a non-approval or delay on the process of getting a drug approved. A delay came to place. Still watch the story for the future.

TOP PICK

They are taking the profits and cash flow from their drug to introduce a second drug, expected next year. (Analysts’ target: $9.50).

BUY

Canadian. Excellent phase 3 product results. A take over target, in a position of being sold right now. They have lots of cash. At this level it’s a dollar below financing. Good product. Would buy at this price.

BUY

Excellent phase 3 results. They are a takeover target, they have lots of cash. Annoyed at management because last month they had 61 million in cash, and decided to put the company up for sale, while at the same time decided to raise money. They can't have it both ways. Nothing wrong with the product. Good one to hold and to buy. Should be stable.

BUY

Had 2 good phase 3 trials. 2nd trial is going on right now. Long-term data was very effective. FDA approval will probably happen in the next year. Probably the best takeout candidate in a biotechnology space.

STRONG BUY

Bought today. Have had great results on their phase 3. They've done their financing, they've got their cash. Go to market probably in 2010, 2011. Likely will be acquired. Mixed view of what the drug could be worth.

DON'T BUY

Think you are arriving at the party late on this one. He would have preferred to buy on the breakout pattern in late 2006.

BUY

Phase 3 shoed their drug did not have side effects. This resulted in a large move in the stock price. Now doing a financing, which will be a net positive for the stock. Could be a takeout or could be a partnership.

WEAK BUY

Management team's not bad. A very, very cheap stock. Have a good balance sheet. Thinks you can make money by buying it here regardless of what happens. Would prefer a larger market cap company.

BUY

Very bullish on this stock. Has a lot of cash. A good price.

Showing 1 to 15 of 16 entries

Theratechnologies Inc (TH.TO) Frequently Asked Questions

What is Theratechnologies Inc stock symbol?

Theratechnologies Inc is a Canadian stock, trading under the symbol TH.TO (previously TH-T on Stockchase) on the Toronto Stock Exchange (TH-CT). It is usually referred to as TSX:TH or TH.TO

Is Theratechnologies Inc a buy or a sell?

In the last year, no analyst issued a Buy, Sell, or Hold rating on TH.TO (previously TH-T on Stockchase) on Stockchase. Read the latest expert commentary for Theratechnologies Inc.

Is Theratechnologies Inc a good investment or a top pick?

Theratechnologies Inc was recommended as a Top Pick by Vincent Delisle on 2003-10-28. Read the latest stock experts ratings for Theratechnologies Inc.

Why is Theratechnologies Inc stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Theratechnologies Inc.

Is Theratechnologies Inc worth watching?

Theratechnologies Inc is followed by 20 investors on Stockchase and is a trending stock that is worth watching.

What is Theratechnologies Inc stock price?

On 2025-09-26, Theratechnologies Inc (TH.TO) stock closed at a price of $4.47.

Most Recent Experts

Jim Cramer - Mad Money

CNBC

Richard Orrell

RN Croft Financial Group

Stockchase Insights

5i Research

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Stan Wong

Private Wealth Management, ScotiaMcleod

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Summer Sale

Theratechnologies Inc (TH.TO)